US Treasury proposes barring new US private investment in Chinese brain-computer interface companies

The US Treasury proposed rules on 22 October 2026 that would prohibit US persons from most new non-public investments in companies that develop or produce brain-computer interfaces and are based in, or owned or controlled from, China, Hong Kong or Macau. The definition covers invasive and non-invasive systems and their software. Brain-computer interfaces sit in the rule's prohibited tier, with no notify-only option, no technical threshold and no small-deal exemption for direct investments. Comments are due by 7 December 2026.

Industry News

Neuralink tests iPhone calls with its speech implant

Neuralink said on 29 October 2026 that its engineers spent 72 hours at the home of a participant in its VOICE speech trial and prototyped features including iPhone call integration, an iOS keyboard for brain-based dictation, lock-screen controls, automatic detection of attempted speech and a Grok agent triggered by thought. A Texas filing registered on 28 October shows Neuralink plans a $2.7 million vivarium at its Austin-area site.

Oct 31 · 4 min read

Industry News

Chinese state television says ultrasound brain stimulation improved conscious behaviour in 13 of 24 patients

China Central Television reported on 29 and 30 October 2026 that, in a study by the Shenzhen Institutes of Advanced Technology, part of the Chinese Academy of Sciences, and Kunming Medical University, 13 of 24 patients with chronic disorders of consciousness showed clear improvement after non-invasive ultrasound stimulation. Chinese media call the device a brain-computer interface, and the reports describe only stimulation. InsideBCI found no published paper on the study and no registration for it on ClinicalTrials.gov.

Oct 31 · 4 min read

Industry News

Precision Neuroscience signs Cleveland Clinic Abu Dhabi as its first research site outside the US

Precision Neuroscience signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi on 21 October 2026, with the support of the Department of Health Abu Dhabi, to evaluate its Layer 7 cortical interface in collaborative clinical research. It is the company's first clinical research site outside the United States. The same hospital hosts Neuralink's UAE-PRIME trial, and Abu Dhabi's Mubadala Capital took part in Precision's $250 million Series D.

Oct 30 · 2 min read

Market Moves

NeuroXess raises RMB 700 million for its brain implant

Shanghai brain-computer interface company NeuroXess announced a RMB 700 million Series B round on 28 October 2026, co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital and described by 36Kr as dominated overall by state capital. The money will fund the multicentre registration trial of its implant for people with quadriplegia, a factory in Jiangxi and next-generation products.

Oct 29 · 4 min read

Industry News

Neuralink says an ALS patient reached 75 words a minute with its speech implant

Neuralink said on 28 October 2026 that one participant with ALS in its VOICE speech trial reached 75 words per minute with a 5.8 per cent word error rate on a 125,000-word vocabulary in their first week. The figures come from a company post and have not been peer-reviewed. They are faster than any published result on a vocabulary that size, and less accurate than the best published results from UC Davis.

Oct 29 · 4 min read

Industry News

Chinese ultrasound maker eSonic signs a cooperation deal with researchers from Mickael Tanter's Paris lab

Beijing-based eSonic launched what it calls the eSonic brain-computer interface platform on 22 October 2026 and signed a Sino-French strategic cooperation with researchers from Mickael Tanter's team, whose Paris lab introduced functional ultrasound imaging of the brain in 2011. The company's only public account is its own press release. No French institution is named as a party, and eSonic cites no published data showing functional ultrasound through an intact adult human skull.

Oct 28 · 5 min read

Industry News

NeuroDoctrine flies three drones with a brain-signal headband in Manchester

Defence start-up NeuroDoctrine, led by neuroscientist Zied Tayeb, flew three small commercial drones with a non-invasive headband reading brain signals over the visual cortex at its Manchester launch in late September 2026. Calibration takes about six hours per user. The company, whose advisers include a former US Special Operations Command science and technology director and a former commander of NATO Allied Land Command, is raising money and wants to sell its system to defence contractors. It has published no test data behind its performance claims.

Oct 28 · 5 min read

Industry News

China approves its first home-grown brainstem hearing implant for children

China's National Medical Products Administration approved Zhejiang Nurotron's WH-01A auditory brainstem implant on 19 October 2026. Developed with Wu Hao's team at Shanghai Ninth People's Hospital, it is approved for children aged 2 to under 6 who lost their hearing before learning to speak and cannot use a cochlear implant because of a severely malformed inner ear or a missing cochlear nerve. In the US, the only approved auditory brainstem implant is limited to patients aged 12 and over with neurofibromatosis type 2.

Oct 26 · 6 min read